Decision Regret May Explain Why Social Support Shapes Quality of Life in Thyroid Cancer Survivors

Papillary thyroid cancer is one of the most survivable malignancies in modern oncology, with five-year survival rates that routinely exceed ninety percent. Yet a growing body of evidence shows that surviving the disease is not the same as living well after it. Many patients who have been declared cured continue to report persistent fatigue, voice changes, anxiety about recurrence, and a diminished sense of well-being that can last for years after surgery. A new cross-sectional study published in BMC Cancer by researchers at Chongqing Medical University and its affiliated hospitals now offers one of the most detailed statistical portraits to date of how unevenly this burden is distributed among survivors, and it identifies a surprisingly specific psychological mechanism that may connect the support patients receive to how they ultimately feel.

The research team, led by Juan Deng and colleagues, surveyed 737 papillary thyroid cancer survivors recruited from three tertiary hospitals in Chongqing, China, between March and June 2025. Rather than treating quality of life as a single average score, the investigators used latent profile analysis, a person-centered statistical technique that sorts individuals into unobserved subgroups based on their response patterns. Their instrument was the Thyroid Cancer-Specific Quality of Life Questionnaire, known as ThyCA-QoL, which was developed by the European Organisation for Research and Treatment of Cancer to capture symptoms and concerns that are particular to thyroid cancer, including neck problems, voice changes, sympathetic arousal, and worries about radioactive iodine therapy.

The analysis revealed that survivors did not fall along a simple continuum of feeling better or worse. Instead, four distinct profiles emerged. The largest group, accounting for 30.0 percent of participants, reported a low symptom burden across the board. A second group, 25.6 percent, was dominated by psychological distress, meaning their worst scores clustered around anxiety, emotional difficulty, and distress related to their diagnosis rather than physical complaints. A third group, 22.5 percent, showed the reverse pattern, with physical symptoms such as neck discomfort, swallowing problems, and voice issues taking precedence. The final group, 21.8 percent, carried a high symptom burden on both fronts, reporting elevated levels of psychological and physical symptoms simultaneously.

This heterogeneity matters clinically because it suggests that a one-size-fits-all follow-up strategy would miss most survivors most of the time. A survivor in the psychological distress dominant profile might benefit most from mental health screening and counseling, while someone in the physical symptom dominant group might need targeted evaluation of surgical sequelae such as recurrent laryngeal nerve injury or hypoparathyroidism. The fact that roughly one in five survivors fell into the high burden category underscores that even a cancer with an excellent prognosis can leave a substantial minority struggling with a compounded symptom load.

The second half of the study addressed a question that has long puzzled researchers in survivorship care: why does social support seem to improve quality of life? Social support, measured here with the Multidimensional Scale of Perceived Social Support, correlated strongly with better quality of life across the sample. But correlation alone does not reveal the pathway. The investigators hypothesized that decision regret, assessed with the Decision Regret Scale, might sit in the middle of that relationship. Decision regret is the distress or self-blame a patient feels after making a treatment choice, particularly when the outcome differs from what was hoped for. In thyroid cancer, where patients often face genuine choices between lobectomy and total thyroidectomy, and sometimes between surgery and active surveillance for very small tumors, the potential for regret is substantial.

Using bootstrap mediation analysis, a resampling technique that estimates the stability of indirect effects, the team found that decision regret statistically accounted for 44.3 percent of the association between social support and quality of life. The indirect effect was negative, with an unstandardized coefficient of minus 0.121 and a 95 percent bootstrap confidence interval spanning minus 0.158 to minus 0.089, meaning that higher social support was associated with lower decision regret, which in turn was associated with better quality of life. The completely standardized indirect effect was minus 0.150, with a confidence interval from minus 0.194 to minus 0.110. Social support and decision regret also differed significantly across the four latent profiles, with a p value below 0.001.

The authors went a step further than most mediation studies by conducting an E-value sensitivity analysis, which quantifies how strong an unmeasured confounder would need to be to explain away the observed association. The E-value of 1.56 indicates that only modest unmeasured confounding would be required to nullify the finding, a point the researchers acknowledge as a limitation. This transparency is valuable because it signals to readers that the mediation result, while statistically robust within the observed data, should be interpreted as evidence of a plausible pathway rather than proof of causation in a cross-sectional design.

The practical implications of the study are nonetheless significant. Because decision regret is a potentially modifiable psychological state, the findings suggest that interventions aimed at improving how patients make and process treatment decisions could meaningfully improve quality of life even when the underlying social environment cannot easily be changed. Shared decision-making practices, in which clinicians present treatment options with balanced information and actively elicit patient values, have been shown in other contexts to reduce regret. Structured decision aids, preoperative counseling sessions, and peer support programs that connect newly diagnosed patients with experienced survivors are all concrete avenues through which the regret pathway might be interrupted.

The study also carries implications for how survivorship care is organized in health systems where papillary thyroid cancer diagnoses have risen sharply, driven in part by increased detection of papillary thyroid microcarcinoma through neck imaging. As the population of long-term survivors grows, distinguishing between those who are thriving and those who are silently struggling becomes an increasingly urgent clinical task. The four-profile framework developed in this study offers a template for risk stratification that goes beyond tumor stage and instead centers the patient’s lived experience.

Limitations remain. The cross-sectional design cannot establish temporal ordering, so it is possible that survivors with poorer quality of life retrospectively report more regret rather than the reverse. The sample was drawn from three tertiary hospitals in a single Chinese city, which may limit generalizability to other health systems and cultural contexts. Self-reported measures are also vulnerable to recall and response biases. Still, the combination of person-centered profiling, formal mediation testing, and sensitivity analysis represents a methodologically careful attempt to untangle a question that matters to hundreds of thousands of survivors worldwide: not just whether they survive thyroid cancer, but how well they live with the decisions that saved them.

Subject of Research: Quality of life symptom profiles and decision regret as a mediator of social support effects in papillary thyroid cancer survivors

Article Title: Quality of life symptom burden heterogeneity in papillary thyroid cancer survivors: latent profiles and the mediating role of decision regret

Article References: Deng, J., Xiang, H., Deng, Q., Chen, Z., Wu, X., & Zhang, L. (2026). Quality of life symptom burden heterogeneity in papillary thyroid cancer survivors: latent profiles and the mediating role of decision regret. BMC Cancer. https://doi.org/10.1186/s12885-026-16922-2

Image Credits: AI Generated

DOI: 10.1186/s12885-026-16922-2

Keywords: papillary thyroid cancer, quality of life, decision regret, social support, latent profile analysis, survivorship care, meditation analysis, ThyCA-QoL, psychological distress, symptom burden, shared decision-making, BMC Cancer